These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 2602679

  • 1. [Clinical effects and plasma concentration levels of aprindine hydrochloride in patients with tachyarrhythmias].
    Kasahara S, Shibata N, Mizobe H, Shoda M, Miyazaki Y, Miura M, Miyazawa Y, Komatsu Y.
    Kokyu To Junkan; 1989 Nov; 37(11):1225-30. PubMed ID: 2602679
    [Abstract] [Full Text] [Related]

  • 2. Non-linear pharmacokinetics of aprindine hydrochloride in oral administration.
    Yokota M, Inagaki H, Uematsu H, Enomoto N, Goto J, Sotobata I, Takahashi A.
    Arzneimittelforschung; 1987 Feb; 37(2):184-8. PubMed ID: 2437934
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of clinical efficacy and plasma levels of aprindine.
    Malini PL, Ambrosioni E, Bracchetti D, Magnani B.
    Int J Clin Pharmacol Biopharm; 1979 Oct; 17(10):396-403. PubMed ID: 500254
    [Abstract] [Full Text] [Related]

  • 4. [Detection of aprindine and its metabolites in plasma and urine].
    Wirth KE, Breithardt G, Michaelis L.
    Herz; 1983 Oct; 8(5):302-8. PubMed ID: 6642401
    [Abstract] [Full Text] [Related]

  • 5. Long-term oral antiarrhythmic therapy with aprindine: effects on cardiac function and adverse effects.
    Tsutsui H, Araki H, Nagata Y, Nakamura M.
    Clin Ther; 1984 Oct; 6(6):770-7. PubMed ID: 6509460
    [Abstract] [Full Text] [Related]

  • 6. Effective plasma concentrations of aprindine in canine ventricular arrhythmias.
    Hashimoto K, Komori S, Ishii M, Kamiya J.
    J Cardiovasc Pharmacol; 1984 Oct; 6(1):12-9. PubMed ID: 6199593
    [Abstract] [Full Text] [Related]

  • 7. [Clinical efficacy and plasma levels of oral aprindine, a new antiarrhythmic drug].
    Kikuchi H, Honda T, Kugimiya H, Matuda H, Matunaga T, Takemiya S, Hayasaki K.
    Kokyu To Junkan; 1985 Mar; 33(3):433-40. PubMed ID: 4012073
    [No Abstract] [Full Text] [Related]

  • 8. Aprindine therapy for refractory ventricular tachycardia.
    Khan AH, Carleton RA, Chown M.
    Arch Intern Med; 1983 Feb; 143(2):229-32. PubMed ID: 6824389
    [Abstract] [Full Text] [Related]

  • 9. Cardiac effects of aprindine in patients with or without cardiac dysfunction: echocardiographic and clinical evaluation.
    Shimada R, Araki H, Orita Y, Nakagaki O, Nakamura M.
    Clin Ther; 1983 Feb; 5(4):348-56. PubMed ID: 6871919
    [Abstract] [Full Text] [Related]

  • 10. Treatment of recurrent ventricular tachycardia and fibrillation with aprindine.
    Fasola AF, Noble RJ, Zipes DP.
    Am J Cardiol; 1977 May 26; 39(6):903-9. PubMed ID: 67800
    [Abstract] [Full Text] [Related]

  • 11. [Effects of intravenous aprindine on hemodynamics in patients with cardiac dysfunction and its pharmacodynamics in patients with premature ventricular contractions].
    Matsumoto N, Hayasaki K.
    Kokyu To Junkan; 1990 Apr 26; 38(4):383-9. PubMed ID: 1694595
    [Abstract] [Full Text] [Related]

  • 12. Long-term follow-up of patients receiving aprindine. Safety and efficacy.
    Strasberg B, Prechel D, Bauman J, Coelho A, Swiryn S, Bauernfeind R, Rosen KM.
    Arch Intern Med; 1983 Nov 26; 143(11):2131-3. PubMed ID: 6639232
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic study of aprindine and moxaprindine in dogs.
    de Suray JM, Lavis A, Breekpot F.
    Int J Clin Pharmacol Ther Toxicol; 1981 May 26; 19(5):209-15. PubMed ID: 7251236
    [Abstract] [Full Text] [Related]

  • 14. The utility of aprindine blood levels in the management of ventricular arrhythmias.
    Vlay SC, Kallman CH, Reid PR.
    J Am Coll Cardiol; 1985 Mar 26; 5(3):738-43. PubMed ID: 3973273
    [Abstract] [Full Text] [Related]

  • 15. [Comparison of the anti-arrhythmic effects of propafenone and aprindine in the treatment of refractory chronic ventricular arrhythmias. A randomized double-blind crossover study controlled with placebo].
    Purcaro A, Amici R, Ciampani N, Costantini C, Mocchegiani R, Pigini G.
    G Ital Cardiol; 1983 Mar 26; 13(6):444-50. PubMed ID: 6357929
    [Abstract] [Full Text] [Related]

  • 16. Ventricular tachycardia: prediction of response to oral aprindine with intravenous aprindine.
    Strasberg B, Palileo E, Prechel D, Bauernfeind R, Swiryn S, Wyndham CR, Dhingra RC, Kehoe R, Rosen KM.
    Am J Cardiol; 1981 Mar 26; 47(3):676-82. PubMed ID: 6781325
    [Abstract] [Full Text] [Related]

  • 17. Aprindine for treatment of ventricular arrhythmias in the dog.
    Muir WW, Bonagura JD.
    Am J Vet Res; 1982 Oct 26; 43(10):1815-9. PubMed ID: 7149383
    [Abstract] [Full Text] [Related]

  • 18. Absorption, half-life, and toxicity of oral aprindine in patients with acute myocardial infarction.
    Hagemeijer F.
    Eur J Clin Pharmacol; 1975 Oct 10; 9(1):21-5. PubMed ID: 1233249
    [Abstract] [Full Text] [Related]

  • 19. Suppression of refractory arrhythmias by aprindine in patients with the Wolff-Parkinson-White syndrome.
    Reid PR, Greene HL, Varghese PJ.
    Br Heart J; 1977 Dec 10; 39(12):1353-60. PubMed ID: 603737
    [Abstract] [Full Text] [Related]

  • 20. Chronic administration of aprindine during maintenance hemodialysis.
    Takata Y, Tsuchihashi T, Nakamura S, Hirota Y.
    Int J Clin Pharmacol Ther; 1997 Dec 10; 35(12):553-6. PubMed ID: 9455712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.